Patents by Inventor Tomoyuki USUI

Tomoyuki USUI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12699102
    Abstract: An object of the present invention is to provide a TARC-containing composition with high storage stability. Provided is a composition including TARC (Thymus and activation-regulated chemokine) and one or more selected from the group consisting of a sugar fatty acid ester-type nonionic surfactant, a polyoxyethylene-polyoxypropylene block copolymer-type nonionic surfactant, and a polyoxyethylene alkylamine-type nonionic surfactant and being in liquid form. The aforementioned object is achieved by the composition.
    Type: Grant
    Filed: July 9, 2021
    Date of Patent: August 4, 2026
    Assignee: SEKISUI MEDICAL CO., LTD.
    Inventors: Akiko Matsumoto, Tomoyuki Usui, Yuka Suzuki, Kengo Fujimura
  • Publication number: 20230266337
    Abstract: An object of the present invention is to provide a TARC-containing composition with high storage stability. Provided is a composition including TARC (Thymus and activation-regulated chemokine) and one or more selected from the group consisting of a sugar fatty acid ester-type nonionic surfactant, a polyoxyethylene-polyoxypropylene block copolymer-type nonionic surfactant, and a polyoxyethylene alkylamine-type nonionic surfactant and being in liquid form. The aforementioned object is achieved by the composition.
    Type: Application
    Filed: July 9, 2021
    Publication date: August 24, 2023
    Applicant: SEKISUI MEDICAL CO., LTD.
    Inventors: Akiko MATSUMOTO, Tomoyuki USUI, Yuka SUZUKI, Kengo FUJIMURA
  • Publication number: 20230258657
    Abstract: An object of the present invention is to provide a TARC-containing composition with high storage stability. Provided is a composition including TARC (Thymus and activation-regulated chemokine) and a polymer having 2-methacryloyloxyethyl phosphorylcholine as a structural unit, and being in liquid form. The aforementioned object is achieved by the composition.
    Type: Application
    Filed: July 9, 2021
    Publication date: August 17, 2023
    Applicant: SEKISUI MEDICAL CO., LTD.
    Inventors: Kengo FUJIMURA, Tomoyuki USUI, Yuka SUZUKI, Akiko MATSUMOTO
  • Publication number: 20230025583
    Abstract: A problem to be solved by the invention is to improve the sensitivity of measurement of an analyte in a sample by a sandwich immunoassay. The sensitivity can be improved significantly in a sandwich immunoassay using a first antibody and a second antibody when one or both of the first antibody and the second antibody are a mixture of a monoclonal antibody recognizing a linear epitope and a monoclonal antibody recognizing a conformational epitope.
    Type: Application
    Filed: November 27, 2020
    Publication date: January 26, 2023
    Applicant: SEKISUI MEDICAL CO., LTD.
    Inventors: Tomohide ASAI, Yoshihiro TANAKA, Ikumi SUZUKI, Satoko SEO, Tomoyuki USUI, Tomo SHIMIZU, Osamu MIYAZAKI